title: Absence of viral rebound after treatment of HIV-infected patients with didanosine and hydroxycarbamide.
authors.forename: J
authors.initials: J
authors.lastname: Vila
authors.forename: F
authors.initials: F
authors.lastname: Nugier
authors.forename: G
authors.initials: G
authors.lastname: Barguès
authors.forename: T
authors.initials: T
authors.lastname: Vallet
authors.forename: D
authors.initials: D
authors.lastname: Peyramond
authors.forename: F
authors.initials: F
authors.lastname: Hamedi-Sangsari
authors.forename: J M
authors.initials: JM
authors.lastname: Seigneurin
mesh_terms: D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D016049:Didanosine / Q000008:administration & dosage / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy* / Q000821:virology*; D015497:HIV-1; D006801:Humans; D006918:Hydroxyurea / Q000008:administration & dosage / Q000627:therapeutic use*; D019384:Nucleic Acid Synthesis Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D013997:Time Factors; D019562:Viral Load
chemical_list: D019380:Anti-HIV Agents; D019384:Nucleic Acid Synthesis Inhibitors; D016049:Didanosine; D006918:Hydroxyurea